Evidence map›Paper›PMID 33215027›Full record

ArticlePediatric gastroenterology, hepatology & nutrition2020

Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China.

Wen Zhang, Ruizhu Lin, Zhikun Lu, Huiying Sheng, Yi Xu, Xiuzhen Li, Jing Cheng, Yanna Cai, Xiaojian Mao, Li Liu

Open access · diamondAbstract read
In one paragraph

Article in Pediatric gastroenterology, hepatology & nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wen ZhangDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-4003-1771
Ruizhu LinDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-2445-386X
Zhikun LuDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0003-4976-8259
Huiying ShengDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0003-4726-9974
Yi XuDepartment of Infectious Disease, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0001-8971-9334
Xiuzhen LiDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0001-5124-3051
Jing ChengDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-8660-0669
Yanna CaiDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0001-8734-5949
Xiaojian MaoDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-4915-4903
Li LiuDepartment of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Guangzhou Women and Children Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeProgressive familial intrahepatic cholestasis (PFIC) is a rare genetic autosomal recessive disease caused by mutations in

methodsWe collected and analyzed relevant data related to clinical diagnosis, biological investigation, and molecular determination in nine children carrying these gene mutations, who were from unrelated families in South China.

resultsOf the nine patients (five males, four females) with PFIC, one case of PFIC1, four cases of PFIC2, and four cases of PFIC3 were diagnosed. Except in patient no. 8, jaundice and severe pruritus were the major clinical signs in all forms. γ-glutamyl transpeptidase was low in patients with PFIC1/PFIC2, and remained mildly elevated in patients with PFIC3. We identified 15 different mutations, including nine novel mutations (p.R470HfsX8, p.Q794X and p.I1170T of ABCB11 gene mutations, p.G319R, p.A1047P, p.G1074R, p.T830NfsX11, p.A1047PfsX8 and p.N1048TfsX of ABCB4 gene mutations) and six known mutations (p.G446R and p.F529del of ATP8B1 gene mutations, p.A588V, p.G1004D and p.R1057X of ABCB11 gene mutations, p.P479L of ABCB4 gene mutations). The results showed that compared with other regions, these three types of PFIC genes had different mutational spectrum in China.

conclusionThe study expands the genotypic spectrum of PFIC. We identified nine novel mutations of PFIC and our findings could help in the diagnosis and treatment of this disease.

Indexed as

GeneIntrahepatic cholestasisMutationPhenotype

Identifiers

PMID33215027
PMCPMC7667226
OpenAlexW3098651365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.